OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 23
Unit: Days
Value type: Mean
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 1606
Country: Hong Kong SAR,  China
Study period: 2 Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Doubling time
Parameter type: Doubling time
Parameter value: 16.2
Unit: Days
Value type: Unspecified
Epidemic phase: Mid outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: China
Study period: 17 Mar 03 2003 to 12 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
CFR/IFR method: Adjusted
Epidemic phase: Mid outbreak
Disaggregated by: Region
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Canada, China, Hong Kong SAR,  China, Singapore, Taiwan,  China, Vietnam
Study period: 10 Apr 04 2003 to 12 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 10.4
Unit: Percentage (%)
Value type: Mean
CFR/IFR method: Adjusted
Epidemic phase: Mid outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Canada, China, Hong Kong SAR,  China, Singapore, Taiwan,  China, Vietnam
Study period: 10 Apr 04 2003 to 21 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 14.7
Unit: Percentage (%)
Value type: Mean
CFR/IFR method: Adjusted
Epidemic phase: Mid outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Canada, China, Hong Kong SAR,  China, Singapore, Taiwan,  China, Vietnam
Study period: 10 Apr 04 2003 to 12 May 05 2003
Pathogen: SARS-CoV
Parameter class: Doubling time
Parameter type: Doubling time
Epidemic phase: Mid outbreak
Disaggregated by: Region
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Canada, China, Hong Kong SAR,  China, Singapore, Taiwan,  China, Vietnam
Study period: 18 Mar 03 2003 to 11 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 19
Unit: Days
Value type: Median
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 11
Uncertainty upper value: 22
Combined uncertainty: 11 - 22 (Inter Quartile Range (IQR) [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 13
Country: Canada
Location: Toronto
Study period:    to 15 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 8
Unit: Days
Value type: Median
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 5
Uncertainty upper value: 10
Combined uncertainty: 5 - 10 (Inter Quartile Range (IQR) [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 38
Country: Canada
Location: Toronto
Study period:    to 15 Apr 04 2003
Other delay start: Symptom Onset/Fever
Other delay end: Admission to Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 8
Unit: Days
Value type: Median
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 6
Uncertainty upper value: 12
Combined uncertainty: 6 - 12 (Inter Quartile Range (IQR) [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 29
Country: Canada
Location: Toronto
Study period:    to 15 Apr 04 2003
Other delay start: Symptom Onset/Fever
Other delay end: Mechanical ventilation
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 10.5
Unit: Days
Value type: Median
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 5
Uncertainty upper value: 28
Combined uncertainty: 5 - 28 (Inter Quartile Range (IQR) [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Country: Canada
Location: Toronto
Study period:    to 15 Apr 04 2003
Other delay start: Admission to Critical Care/ICU
Other delay end: Discharge from Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Cormobidity;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 38
Country: Canada
Location: Toronto
Study period:    to 15 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Occupation;Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 38
Country: Canada
Study period:    to 15 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 5
Unit: Days
Value type: Median
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 2
Uncertainty upper value: 7
Combined uncertainty: 2 - 7 (Inter Quartile Range (IQR) [Sample])
Epidemic phase: Mid outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 38
Country: Canada
Location: Toronto
Study period:    to 15 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Disaggregated by: Occupation
Risk factor: Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 76
Country: Canada
Location: Toronto
Study period: 1 Apr 04 2003 to 22 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 10.7
Unit: Days
Value type: Mean
Uncertainty single value: 3.8 (Standard deviation (Sd) [Sample])
Combined uncertainty: 3.8 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 24
Maximum age: 74
Sample size: 30
Country: China
Location: DiTan Hospital, Beijing
Study period: 22 Apr 04 2003 to   
Other delay start: Symptom Onset/Fever
Other delay end: Acute respiratory failure
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Unit: Days
Lower bound: 3
Upper bound: 20
Bounds: 3 - 20
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Unspecified
Sample size: 21
Country: China
Location: DiTan Hospital, Beijing
Study period: 22 Apr 04 2003 to   
Other delay start: Symptom Onset/Fever
Other delay end: CO2 retention
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 1.2
Unit: Days
Value type: Mean
Uncertainty type: Range [Sample]
Uncertainty lower value: 0
Uncertainty upper value: 10
Uncertainty single value: 1.6 (Standard deviation (Sd) [Sample])
Combined uncertainty: 0 - 10 (Range [Sample])
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Unspecified
Sample size: 27
Country: China
Location: DiTan Hospital, Beijing
Study period: 22 Apr 04 2003 to   
Other delay start: Respiratory failure
Other delay end: Initiation of noninvasive positive pressure ventilation
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 8.3
Unit: Days
Value type: Mean
Uncertainty type: Range [Sample]
Uncertainty lower value: 5
Uncertainty upper value: 13
Uncertainty single value: 2.9 (Standard deviation (Sd) [Sample])
Combined uncertainty: 5 - 13 (Range [Sample])
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Unspecified
Sample size: 10
Country: China
Location: DiTan Hospital, Beijing
Study period: 22 Apr 04 2003 to   
Other delay start: Initiation of noninvasive positive pressure ventilation
Other delay end: Intubation
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 5.6
Unit: Days
Value type: Mean
Uncertainty type: Range [Sample]
Uncertainty lower value: 2
Uncertainty upper value: 9
Uncertainty single value: 2.2 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2 - 9 (Range [Sample])
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Unspecified
Sample size: 6
Country: China
Location: DiTan Hospital, Beijing
Study period: 22 Apr 04 2003 to   
Other delay start: Initiation of noninvasive positive pressure ventilation
Other delay end: Recognition of barotrauma
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 6.7
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 8
CFR/IFR denominator: 120
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 120
Country: China
Location: DiTan Hospital, Beijing
Study period: 22 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 26.7
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 8
CFR/IFR denominator: 30
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Sample size: 30
Country: China
Location: DiTan Hospital, Beijing
Study period: 22 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 25.9
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 14
CFR/IFR denominator: 54
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 54
Study period: 12 Mar 03 2003 to 18 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 6.4
Unit: Days
Value type: Mean
Uncertainty single value: 6 (Standard deviation (Sd) [Sample])
Combined uncertainty: 6 (Standard deviation (Sd) [Sample])
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 54
Study period: 12 Mar 03 2003 to 18 Apr 04 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Admission to Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 9.6
Unit: Days
Value type: Mean
Uncertainty single value: 4.6 (Standard deviation (Sd) [Sample])
Combined uncertainty: 4.6 (Standard deviation (Sd) [Sample])
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 54
Study period: 12 Mar 03 2003 to 18 Apr 04 2003
Other delay start: Symptom Onset/Fever
Other delay end: Admission to Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 8.5
Unit: Days
Value type: Median
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 5
Uncertainty upper value: 22.3
Combined uncertainty: 5 - 22.3 (Inter Quartile Range (IQR) [Sample])
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 54
Study period: 12 Mar 03 2003 to 18 Apr 04 2003
Other delay start: Admission to Critical Care/ICU
Other delay end: Discharge from Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 14
Unit: Days
Value type: Median
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 8
Uncertainty upper value: 25
Combined uncertainty: 8 - 25 (Inter Quartile Range (IQR) [Sample])
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 27
Study period: 12 Mar 03 2003 to 18 Apr 04 2003
Other delay start: Treatment with mechanical ventilation
Other delay end: Cessation of mechanical ventilation
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Cormobidity;Other
Risk factor outcome: Recovery
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 54
Study period: 12 Mar 03 2003 to 18 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Parameter value: 2.67
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 1.15
Uncertainty upper value: 6.11
Combined uncertainty: 1.15 - 6.11 (95% CI)
Risk factor: Occupation
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Unspecified
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 182
Country: Hong Kong SAR,  China
Study period: 13 Mar 03 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 13
Unit: Days
Uncertainty type: IQR
Uncertainty lower value: 6
Uncertainty upper value: 24
Combined uncertainty: 6 - 24 (IQR)
Sample type: Hospital based
Sex: Both
Sample size: 67
Country: Hong Kong SAR,  China
Study period: 13 Mar 03 2003 to 31 May 05 2003
Other delay start: Admission to Critical Care/ICU
Other delay end: Discharge from Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 9.5
Unit: Days
Uncertainty single value: 4.7 (Standard Deviation)
Combined uncertainty: 4.7 (Standard Deviation)
Sample type: Hospital based
Sex: Both
Sample size: 67
Country: Hong Kong SAR,  China
Study period: 13 Mar 03 2003 to 31 May 05 2003
Other delay start: Symptom Onset/Fever
Other delay end: Admission to Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - infectious period
Parameter value: 8.3
Unit: Days
Value type: Unspecified
Uncertainty type: 95% CI
Uncertainty lower value: 5.8
Uncertainty upper value: 14.3
Combined uncertainty: 5.8 - 14.3 (95% CI)
Country: Singapore
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 6.4
Unit: Days
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 5.2
Uncertainty upper value: 7.7
Combined uncertainty: 5.2 - 7.7 (95% CI)
Epidemic phase: Start outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 1425
Country: Hong Kong SAR,  China
Study period: 20 Feb 02 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Unit: Days
Value type: Mean
Lower bound: 3
Upper bound: 5
Bounds: 3 - 5
Distribution type: Gamma
Epidemic phase: Start outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 1425
Country: Hong Kong SAR,  China
Study period: 20 Feb 02 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 13.2
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 9.8
Uncertainty upper value: 16.8
Combined uncertainty: 9.8 - 16.8 (95% CI)
Epidemic phase: Start outbreak
Disaggregated by: Age
Population group: General population
Sample type: Hospital based
Sex: Both
Maximum age: 60
Sample size: 1425
Country: Hong Kong SAR,  China
Study period: 20 Feb 02 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 6.37
Unit: Days
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 5.29
Uncertainty upper value: 7.75
Uncertainty single value: 16.69 (Variance)
Combined uncertainty: 5.29 - 7.75 (95% CI)
Distribution type: Gamma
Epidemic phase: Start outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 1425
Country: Hong Kong SAR,  China
Study period: 20 Feb 02 2003 to 28 Apr 04 2003
Other delay start: Exposure/Infection
Other delay end: Symptom Onset/Fever
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 35.9
Unit: Days
Value type: Mean
Uncertainty single value: 572.9 (Variance)
Combined uncertainty: 572.9 (Variance)
Epidemic phase: Start outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 1425
Country: Hong Kong SAR,  China
Study period: 20 Feb 02 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 43.3
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 35.2
Uncertainty upper value: 52.4
Combined uncertainty: 35.2 - 52.4 (95% CI)
Epidemic phase: Start outbreak
Disaggregated by: Age
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 60
Sample size: 1425
Country: Hong Kong SAR,  China
Study period: 20 Feb 02 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 23.5
Unit: Days
Value type: Mean
Uncertainty single value: 62.1 (Variance)
Combined uncertainty: 62.1 (Variance)
Distribution type: Gamma
Epidemic phase: Start outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 1425
Country: Hong Kong SAR,  China
Study period: 20 Feb 02 2003 to 28 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 1.1
Lower bound: 1.1
Upper bound: 1.2
Bounds: 1.1 - 1.2
Reproduction number method: Growth rate
Reproduction number pathway: Human-human
Sample type: Population based
Sex: Both
Country: Canada, Hong Kong SAR,  China, Singapore
Location: Ontario (Canada), Singapore, Hong Kong
Study period:   2003 to 25 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 0.58
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 0.24
Uncertainty upper value: 1.18
Combined uncertainty: 0.24 - 1.18 (IQR)
Reproduction number method: Unspecified
Reproduction number pathway: Unspecified
Country: Canada
Location: Toronto
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 1.1
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 0.44
Uncertainty upper value: 2.29
Combined uncertainty: 0.44 - 2.29 (IQR)
Reproduction number method: Unspecified
Reproduction number pathway: Unspecified
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 1.17
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 0.47
Uncertainty upper value: 2.47
Combined uncertainty: 0.47 - 2.47 (IQR)
Reproduction number method: Unspecified
Reproduction number pathway: Unspecified
Country: Singapore
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.95
Unit: No units
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 0.67
Uncertainty upper value: 1.23
Combined uncertainty: 0.67 - 1.23 (95% CI)
Distribution type: Negative-Binomial
Reproduction number method: Branching process
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Country: Canada, Singapore
Location: Toronto, Singapore
Study period: 23 Feb 02 2003 to 11 May 05 2003
Pathogen: SARS-CoV
Parameter class: Overdispersion
Parameter type: Overdispersion
Parameter value: 0.2
Unit: No units
Value type: Other
Uncertainty type: 95% CI
Uncertainty lower value: 0.13
Uncertainty upper value: 0.27
Combined uncertainty: 0.13 - 0.27 (95% CI)
Distribution type: Negative-Binomial
Reproduction number method: Branching process
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Country: Canada
Location: Toronto, Singapore
Study period: 23 Feb 02 2003 to 11 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Unit: Days
Lower bound: 3
Upper bound: 8
Bounds: 3 - 8
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 15
Country: Singapore
Location: Singapore General Hospital
Study period: 24 Mar 03 2003 to 15 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 3.16
Uncertainty single value: 2.25 (Standard Deviation)
Combined uncertainty: 2.25 (Standard Deviation)
Epidemic phase: Start outbreak
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period: 24 Feb 02 2003 to 24 Mar 03 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Parameter value: 0.861
Uncertainty single value: 0.413 (Standard Deviation)
Combined uncertainty: 0.413 (Standard Deviation)
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Sex: Unspecified
Study period: 24 Mar 03 2003 to 2 May 05 2023
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3.8
Unit: Days
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 3.7
Uncertainty upper value: 4
Combined uncertainty: 3.7 - 4 (95% CI)
Disaggregated by: Age, Occupation, Other, Region, Sex, Time
Population group: Persons under investigation
Sample type: Population based
Sample size: 5258
Country: China
Study period: 16 Nov 11 2002 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 29.7
Unit: Days
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 29.3
Uncertainty upper value: 30
Combined uncertainty: 29.3 - 30 (95% CI)
Disaggregated by: Age, Occupation, Other, Region, Sex, Time
Population group: Persons under investigation
Sample type: Population based
Sample size: 4591
Country: China
Study period: 16 Nov 11 2002 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 11.7
Unit: Days
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 10.6
Uncertainty upper value: 13
Combined uncertainty: 10.6 - 13 (95% CI)
Disaggregated by: Age, Occupation, Other, Region, Sex, Time
Population group: Persons under investigation
Sample type: Population based
Sample size: 343
Country: China
Study period: 16 Nov 11 2002 to 28 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 6.4
Unit: Percentage (%)
CFR/IFR numerator: 5327
CFR/IFR denominator: 343
CFR/IFR method: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Sample size: 5327
Country: China
Study period: 16 Nov 11 2002 to 28 May 05 2003